SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-24-041339
Filing Date
2024-05-09
Accepted
2024-05-09 16:31:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea0205661-424b3_protara.htm 424B3 253004
2 GRAPHIC image_001.jpg GRAPHIC 5675
  Complete submission text file 0001213900-24-041339.txt   262191
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-279067 | Film No.: 24931278
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)